Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Pancreatic Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Motor Activity 1 Melanoma 1 Lymphoma, B-Cell 1 Head and Neck Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1

Interventions

Rituximab 2 venetoclax 1 tafasitamab 1 pembrolizumab 1 glofitamab 1 fludarabine 1 avelumab 1 Valproic Acid 1 Melphalan 1 Ifosfamide 1 Gemcitabine 1 Etoposide 1 Dexamethasone 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Lymphoma, B-Cell × avelumab × Clear all

NCT03244176 2024-07-30

AvR-CHOP

Austin Health

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡